Del Mar, CA, United States of America

Debra L Robertson


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debra L. Robertson: Innovator in Oligonucleotide Research

Introduction

Debra L. Robertson is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of drug discovery and molecular biology. Her innovative work focuses on the identification of novel drugs and reagents, particularly through the use of oligonucleotides.

Latest Patents

Debra holds a patent for the "Identification of novel drugs and reagents." This patent discloses methods for identifying oligonucleotides that have a desired activity in vivo. In accordance with preferred embodiments, her work identifies oligonucleotides capable of conferring a desired phenotype. The therapeutic, diagnostic, and research methods and compositions that employ such oligonucleotides are groundbreaking. Notably, prior knowledge of the sequence or structure of a target molecule is generally not required, which enhances the versatility of her methods.

Career Highlights

Debra is associated with Isis Pharmaceuticals, Inc., where she continues to advance her research. Her work has positioned her as a key figure in the biotechnology sector, contributing to the development of innovative therapeutic solutions.

Collaborations

Throughout her career, Debra has collaborated with notable colleagues, including Christopher K. Mirabelli and David J. Ecker. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Debra L. Robertson's contributions to the field of oligonucleotide research exemplify her innovative spirit and dedication to advancing medical science. Her patent and ongoing work at Isis Pharmaceuticals, Inc. highlight her role as a leading inventor in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…